Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Genome polyprotein [Cleaved into: Core protein p21 (Capsid protein C) (p21); Core protein p19; Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); p7; Protease NS2-3 (p23) (EC 3.4.22.-); Serine protease NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3P) (p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]

 POLG_HCVCO              Reviewed;        3010 AA.
Q9WMX2;
05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
23-JAN-2007, sequence version 3.
25-OCT-2017, entry version 163.
RecName: Full=Genome polyprotein;
Contains:
RecName: Full=Core protein p21;
AltName: Full=Capsid protein C;
AltName: Full=p21;
Contains:
RecName: Full=Core protein p19;
Contains:
RecName: Full=Envelope glycoprotein E1;
AltName: Full=gp32;
AltName: Full=gp35;
Contains:
RecName: Full=Envelope glycoprotein E2;
AltName: Full=NS1;
AltName: Full=gp68;
AltName: Full=gp70;
Contains:
RecName: Full=p7;
Contains:
RecName: Full=Protease NS2-3;
Short=p23;
EC=3.4.22.-;
Contains:
RecName: Full=Serine protease NS3;
EC=3.4.21.98;
EC=3.6.1.15;
EC=3.6.4.13;
AltName: Full=Hepacivirin;
AltName: Full=NS3P;
AltName: Full=p70;
Contains:
RecName: Full=Non-structural protein 4A;
Short=NS4A;
AltName: Full=p8;
Contains:
RecName: Full=Non-structural protein 4B;
Short=NS4B;
AltName: Full=p27;
Contains:
RecName: Full=Non-structural protein 5A;
Short=NS5A;
AltName: Full=p56;
Contains:
RecName: Full=RNA-directed RNA polymerase;
EC=2.7.7.48;
AltName: Full=NS5B;
AltName: Full=p68;
Hepatitis C virus genotype 1b (isolate Con1) (HCV).
Viruses; ssRNA viruses; ssRNA positive-strand viruses, no DNA stage;
Flaviviridae; Hepacivirus.
NCBI_TaxID=333284;
NCBI_TaxID=9606; Homo sapiens (Human).
[1]
NUCLEOTIDE SEQUENCE [GENOMIC RNA].
PubMed=10390360; DOI=10.1126/science.285.5424.110;
Lohmann V., Koerner F., Koch J.O., Herian U., Theilmann L.,
Bartenschlager R.;
"Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell
line.";
Science 285:110-113(1999).
[2]
FUNCTION OF NS3 AND NS4A.
PubMed=12702807; DOI=10.1126/science.1082604;
Foy E., Li K., Wang C., Sumpter R. Jr., Ikeda M., Lemon S.M.,
Gale M. Jr.;
"Regulation of interferon regulatory factor-3 by the hepatitis C virus
serine protease.";
Science 300:1145-1148(2003).
[3]
FUNCTION OF NS5A.
PubMed=15542681; DOI=10.1128/JVI.78.23.13306-13314.2004;
Neddermann P., Quintavalle M., Di Pietro C., Clementi A.,
Cerretani M., Altamura S., Bartholomew L., De Francesco R.;
"Reduction of hepatitis C virus NS5A hyperphosphorylation by selective
inhibition of cellular kinases activates viral RNA replication in cell
culture.";
J. Virol. 78:13306-13314(2004).
[4]
PHOSPHORYLATION AT SER-2194; SER-2197; SER-2201 AND SER-2204, AND
MUTAGENESIS OF SER-2158; SER-2173; SER-2179; SER-2194; SER-2197;
SER-2200; SER-2201; SER-2202; SER-2204; SER-2207; SER-2210; SER-2246;
SER-2255 AND SER-2269.
PubMed=15709040; DOI=10.1128/JVI.79.5.3187-3194.2005;
Appel N., Pietschmann T., Bartenschlager R.;
"Mutational analysis of hepatitis C virus nonstructural protein 5A:
potential role of differential phosphorylation in RNA replication and
identification of a genetically flexible domain.";
J. Virol. 79:3187-3194(2005).
[5]
INTERACTION WITH HUMAN TBK1.
PubMed=15841462; DOI=10.1002/hep.20666;
Otsuka M., Kato N., Moriyama M., Taniguchi H., Wang Y., Dharel N.,
Kawabe T., Omata M.;
"Interaction between the HCV NS3 protein and the host TBK1 protein
leads to inhibition of cellular antiviral responses.";
Hepatology 41:1004-1012(2005).
[6]
PHOSPHORYLATION BY HOST CSNK1A1.
STRAIN=Isolate HCV-AT;
PubMed=16943283; DOI=10.1128/JVI.01465-06;
Quintavalle M., Sambucini S., Di Pietro C., De Francesco R.,
Neddermann P.;
"The alpha isoform of protein kinase CKI is responsible for hepatitis
C virus NS5A hyperphosphorylation.";
J. Virol. 80:11305-11312(2006).
[7]
REVIEW.
PubMed=10718937; DOI=10.1046/j.1365-2893.2000.00201.x;
McLauchlan J.;
"Properties of the hepatitis C virus core protein: a structural
protein that modulates cellular processes.";
J. Viral Hepat. 7:2-14(2000).
[8]
REVIEW, AND SUBCELLULAR LOCATION.
PubMed=14752815; DOI=10.1002/hep.20032;
Penin F., Dubuisson J., Rey F.A., Moradpour D., Pawlotsky J.-M.;
"Structural biology of hepatitis C virus.";
Hepatology 39:5-19(2004).
[9]
INTERACTION WITH HNRNPA1 AND SEPT6.
PubMed=17229681; DOI=10.1128/JVI.01311-06;
Kim C.S., Seol S.K., Song O.-K., Park J.H., Jang S.K.;
"An RNA-binding protein, hnRNP A1, and a scaffold protein, septin 6,
facilitate hepatitis C virus replication.";
J. Virol. 81:3852-3865(2007).
[10]
X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 2008-2170, DISULFIDE BOND,
AND COFACTOR (NS5A).
PubMed=15902263; DOI=10.1038/nature03580;
Tellinghuisen T.L., Marcotrigiano J., Rice C.M.;
"Structure of the zinc-binding domain of an essential component of the
hepatitis C virus replicase.";
Nature 435:374-379(2005).
[11]
X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 2005-2174 IN COMPLEX WITH
ZINC, AND COFACTOR (NS5A).
PubMed=19244328; DOI=10.1128/JVI.02352-08;
Love R.A., Brodsky O., Hickey M.J., Wells P.A., Cronin C.N.;
"Crystal structure of a novel dimeric form of NS5A domain I protein
from hepatitis C virus.";
J. Virol. 83:4395-4403(2009).
-!- FUNCTION: Core protein packages viral RNA to form a viral
nucleocapsid, and promotes virion budding. Modulates viral
translation initiation by interacting with HCV IRES and 40S
ribosomal subunit. Also regulates many host cellular functions
such as signaling pathways and apoptosis. Prevents the
establishment of cellular antiviral state by blocking the
interferon-alpha/beta (IFN-alpha/beta) and IFN-gamma signaling
pathways and by inducing human STAT1 degradation. Thought to play
a role in virus-mediated cell transformation leading to
hepatocellular carcinomas. Interacts with, and activates STAT3
leading to cellular transformation. May repress the promoter of
p53, and sequester CREB3 and SP110 isoform 3/Sp110b in the
cytoplasm. Also represses cell cycle negative regulating factor
CDKN1A, thereby interrupting an important check point of normal
cell cycle regulation. Targets transcription factors involved in
the regulation of inflammatory responses and in the immune
response: suppresses NK-kappaB activation, and activates AP-1.
Could mediate apoptotic pathways through association with TNF-type
receptors TNFRSF1A and LTBR, although its effect on death
receptor-induced apoptosis remains controversial. Enhances TRAIL
mediated apoptosis, suggesting that it might play a role in
immune-mediated liver cell injury. Seric core protein is able to
bind C1QR1 at the T-cell surface, resulting in down-regulation of
T-lymphocytes proliferation. May transactivate human MYC, Rous
sarcoma virus LTR, and SV40 promoters. May suppress the human FOS
and HIV-1 LTR activity. Alters lipid metabolism by interacting
with hepatocellular proteins involved in lipid accumulation and
storage. Core protein induces up-regulation of FAS promoter
activity, and thereby probably contributes to the increased
triglyceride accumulation in hepatocytes (steatosis) (By
similarity). {ECO:0000250}.
-!- FUNCTION: E1 and E2 glycoproteins form a heterodimer that is
involved in virus attachment to the host cell, virion
internalization through clathrin-dependent endocytosis and fusion
with host membrane. E1/E2 heterodimer binds to human LDLR, CD81
and SCARB1/SR-BI receptors, but this binding is not sufficient for
infection, some additional liver specific cofactors may be needed.
The fusion function may possibly be carried by E1. E2 inhibits
human EIF2AK2/PKR activation, preventing the establishment of an
antiviral state. E2 is a viral ligand for CD209/DC-SIGN and
CLEC4M/DC-SIGNR, which are respectively found on dendritic cells
(DCs), and on liver sinusoidal endothelial cells and macrophage-
like cells of lymph node sinuses. These interactions allow capture
of circulating HCV particles by these cells and subsequent
transmission to permissive cells. DCs act as sentinels in various
tissues where they entrap pathogens and convey them to local
lymphoid tissue or lymph node for establishment of immunity.
Capture of circulating HCV particles by these SIGN+ cells may
facilitate virus infection of proximal hepatocytes and lymphocyte
subpopulations and may be essential for the establishment of
persistent infection (By similarity). {ECO:0000250}.
-!- FUNCTION: P7 seems to be a heptameric ion channel protein
(viroporin) and is inhibited by the antiviral drug amantadine.
Also inhibited by long-alkyl-chain iminosugar derivatives.
Essential for infectivity (By similarity). {ECO:0000250}.
-!- FUNCTION: Protease NS2-3 is a cysteine protease responsible for
the autocatalytic cleavage of NS2-NS3. Seems to undergo self-
inactivation following maturation (By similarity). {ECO:0000250}.
-!- FUNCTION: NS3 displays three enzymatic activities: serine
protease, NTPase and RNA helicase. NS3 serine protease, in
association with NS4A, is responsible for the cleavages of NS3-
NS4A, NS4A-NS4B, NS4B-NS5A and NS5A-NS5B. NS3 RNA helicase binds
to RNA and unwinds dsRNA in the 3' to 5' direction, and likely RNA
stable secondary structure in the template strand. Cleaves the
host antiviral protein MAVS (By similarity). NS3/NS4A complex also
prevents phosphorylation of human IRF3, thus preventing the
establishment of dsRNA induced antiviral state. {ECO:0000250,
ECO:0000269|PubMed:12702807, ECO:0000269|PubMed:15542681}.
-!- FUNCTION: NS4B induces a specific membrane alteration that serves
as a scaffold for the virus replication complex. This membrane
alteration gives rise to the so-called ER-derived membranous web
that contains the replication complex (By similarity).
{ECO:0000250}.
-!- FUNCTION: NS5A is a component of the replication complex involved
in RNA-binding. Its interaction with Human VAPB may target the
viral replication complex to vesicles. Down-regulates viral IRES
translation initiation. Mediates interferon resistance, presumably
by interacting with and inhibiting human EIF2AK2/PKR. Seems to
inhibit apoptosis by interacting with BIN1 and FKBP8. The
hyperphosphorylated form of NS5A is an inhibitor of viral
replication (By similarity). {ECO:0000250}.
-!- FUNCTION: NS5B is an RNA-dependent RNA polymerase that plays an
essential role in the virus replication. {ECO:0000250}.
-!- CATALYTIC ACTIVITY: Hydrolysis of four peptide bonds in the viral
precursor polyprotein, commonly with Asp or Glu in the P6
position, Cys or Thr in P1 and Ser or Ala in P1'.
-!- CATALYTIC ACTIVITY: Nucleoside triphosphate + RNA(n) = diphosphate
+ RNA(n+1). {ECO:0000255|PROSITE-ProRule:PRU00539}.
-!- CATALYTIC ACTIVITY: NTP + H(2)O = NDP + phosphate.
-!- CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate.
-!- COFACTOR:
Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
Note=Binds 1 zinc ion per NS3 protease domain. {ECO:0000250};
-!- COFACTOR:
Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
Evidence={ECO:0000269|PubMed:15902263,
ECO:0000269|PubMed:19244328};
Note=Binds 1 zinc ion per NS5A N-terminal domain.
{ECO:0000269|PubMed:15902263, ECO:0000269|PubMed:19244328};
-!- ENZYME REGULATION: Activity of auto-protease NS2-3 is dependent on
zinc ions and completely inhibited by EDTA. Serine protease NS3 is
also activated by zinc ions (By similarity). {ECO:0000250}.
-!- SUBUNIT: Core protein is a homomultimer that binds the C-terminal
part of E1 and interacts with numerous cellular proteins.
Interaction with human STAT1 SH2 domain seems to result in
decreased STAT1 phosphorylation, leading to decreased IFN-
stimulated gene transcription. In addition to blocking the
formation of phosphorylated STAT1, the core protein also promotes
ubiquitin-mediated proteasome-dependent degradation of STAT1.
Interacts with, and constitutively activates human STAT3.
Associates with human LTBR and TNFRSF1A receptors and possibly
induces apoptosis. Binds to human SP110 isoform 3/Sp110b, HNRPK,
C1QR1, YWHAE, UBE3A/E6AP, DDX3X, APOA2 and RXRA proteins.
Interacts with human CREB3 nuclear transcription protein,
triggering cell transformation. May interact with human p53. Also
binds human cytokeratins KRT8, KRT18, KRT19 and VIM (vimentin). E1
and E2 glycoproteins form a heterodimer that binds to human LDLR,
CLDN1, CD81 and SCARB1 receptors. E2 binds and inhibits human
EIF2AK2/PKR. Also binds human CD209/DC-SIGN and CLEC4M/DC-SIGNR.
p7 forms a homoheptamer in vitro. NS2 forms a homodimer containing
a pair of composite active sites at the dimerization interface.
NS2 seems to interact with all other non-structural (NS) proteins.
NS4A interacts with NS3 serine protease and stabilizes its
folding. NS3-NS4A complex is essential for the activation of the
latter and allows membrane anchorage of NS3. NS3 interacts with
human TANK-binding kinase TBK1 and MAVS. NS4B and NS5A form
homodimers and seem to interact with all other non-structural (NS)
proteins. NS5A also interacts with human EIF2AK2/PKR, FKBP8, GRB2,
BIN1, PIK3R1, SRCAP, VAPB and with most Src-family kinases. NS5B
is a homooligomer and interacts with human VAPB, HNRNPA1 and SEPT6
(By similarity). {ECO:0000250}.
-!- INTERACTION:
P26663:- (xeno); NbExp=5; IntAct=EBI-6863741, EBI-6874437;
O14874:BCKDK (xeno); NbExp=2; IntAct=EBI-6863741, EBI-1046765;
O00499:BIN1 (xeno); NbExp=5; IntAct=EBI-6863748, EBI-719094;
Q13137:CALCOCO2 (xeno); NbExp=3; IntAct=EBI-6863741, EBI-739580;
Q6P2H3:CEP85 (xeno); NbExp=2; IntAct=EBI-6863741, EBI-2808308;
O00571:DDX3X (xeno); NbExp=4; IntAct=EBI-6863754, EBI-353779;
Q12805:EFEMP1 (xeno); NbExp=2; IntAct=EBI-6863748, EBI-536772;
Q9GZT9:EGLN1 (xeno); NbExp=3; IntAct=EBI-6863748, EBI-1174818;
Q9NRA8:EIF4ENIF1 (xeno); NbExp=3; IntAct=EBI-6863741, EBI-301024;
Q9UPT5:EXOC7 (xeno); NbExp=3; IntAct=EBI-710918, EBI-720048;
Q13451:FKBP5 (xeno); NbExp=4; IntAct=EBI-9005440, EBI-306914;
O75344:FKBP6 (xeno); NbExp=6; IntAct=EBI-6863748, EBI-744771;
Q14318:FKBP8 (xeno); NbExp=11; IntAct=EBI-6863748, EBI-724839;
P21333:FLNA (xeno); NbExp=6; IntAct=EBI-6863748, EBI-350432;
O43559:FRS3 (xeno); NbExp=3; IntAct=EBI-6863741, EBI-725515;
P06241:FYN (xeno); NbExp=2; IntAct=EBI-710918, EBI-515315;
P32456:GBP2 (xeno); NbExp=2; IntAct=EBI-6863741, EBI-714388;
Q08379:GOLGA2 (xeno); NbExp=2; IntAct=EBI-6863748, EBI-618309;
Q13227:GPS2 (xeno); NbExp=2; IntAct=EBI-6863748, EBI-713355;
Q9P035:HACD3 (xeno); NbExp=3; IntAct=EBI-6863748, EBI-359013;
Q53GQ0:HSD17B12 (xeno); NbExp=2; IntAct=EBI-6863754, EBI-2963255;
P20701:ITGAL (xeno); NbExp=2; IntAct=EBI-6863748, EBI-961214;
P52294:KPNA1 (xeno); NbExp=2; IntAct=EBI-6863741, EBI-358383;
Q14974:KPNB1 (xeno); NbExp=2; IntAct=EBI-710918, EBI-286758;
O43504:LAMTOR5 (xeno); NbExp=2; IntAct=EBI-9028527, EBI-713382;
P07948:LYN (xeno); NbExp=3; IntAct=EBI-710918, EBI-79452;
Q9H8S9:MOB1A (xeno); NbExp=2; IntAct=EBI-6863748, EBI-748229;
P11586:MTHFD1 (xeno); NbExp=3; IntAct=EBI-710918, EBI-709638;
Q9ULW6:NAP1L2 (xeno); NbExp=2; IntAct=EBI-6863748, EBI-3911716;
P22736:NR4A1 (xeno); NbExp=2; IntAct=EBI-9028517, EBI-721550;
P14618:PKM (xeno); NbExp=4; IntAct=EBI-710918, EBI-353408;
O60664:PLIN3 (xeno); NbExp=5; IntAct=EBI-6863748, EBI-725795;
O15162:PLSCR1 (xeno); NbExp=8; IntAct=EBI-710918, EBI-740019;
P23284:PPIB (xeno); NbExp=7; IntAct=EBI-9005440, EBI-359252;
Q8WUF5:PPP1R13L (xeno); NbExp=2; IntAct=EBI-6863748, EBI-5550163;
P28065:PSMB9 (xeno); NbExp=2; IntAct=EBI-6863748, EBI-603300;
Q9UJF2:RASAL2 (xeno); NbExp=2; IntAct=EBI-6863741, EBI-359444;
Q9HAU4:SMURF2 (xeno); NbExp=2; IntAct=EBI-6863741, EBI-396727;
O94875:SORBS2 (xeno); NbExp=2; IntAct=EBI-6863748, EBI-311323;
P27105:STOM (xeno); NbExp=3; IntAct=EBI-9005440, EBI-1211440;
Q13148:TARDBP (xeno); NbExp=2; IntAct=EBI-710918, EBI-372899;
Q6PKC3:TXNDC11 (xeno); NbExp=2; IntAct=EBI-6863748, EBI-749812;
Q9P0L0:VAPA (xeno); NbExp=4; IntAct=EBI-9005440, EBI-1059156;
Q8N1B4:VPS52 (xeno); NbExp=2; IntAct=EBI-6863748, EBI-2799833;
O14980:XPO1 (xeno); NbExp=3; IntAct=EBI-710918, EBI-355867;
-!- SUBCELLULAR LOCATION: Core protein p21: Host endoplasmic reticulum
membrane {ECO:0000250}; Single-pass membrane protein
{ECO:0000250}. Host mitochondrion membrane {ECO:0000250}; Single-
pass type I membrane protein {ECO:0000250}. Host lipid droplet
{ECO:0000250}. Note=The C-terminal transmembrane domain of core
protein p21 contains an ER signal leading the nascent polyprotein
to the ER membrane. Only a minor proportion of core protein is
present in the nucleus and an unknown proportion is secreted.
-!- SUBCELLULAR LOCATION: Core protein p19: Virion {ECO:0000250}. Host
cytoplasm {ECO:0000250}. Host nucleus {ECO:0000250}. Secreted
{ECO:0000250}.
-!- SUBCELLULAR LOCATION: Envelope glycoprotein E1: Virion membrane
{ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.
Host endoplasmic reticulum membrane {ECO:0000250}; Single-pass
type I membrane protein {ECO:0000250}. Note=The C-terminal
transmembrane domain acts as a signal sequence and forms a hairpin
structure before cleavage by host signal peptidase. After
cleavage, the membrane sequence is retained at the C-terminus of
the protein, serving as ER membrane anchor. A reorientation of the
second hydrophobic stretch occurs after cleavage producing a
single reoriented transmembrane domain. These events explain the
final topology of the protein. ER retention of E1 is leaky and, in
overexpression conditions, only a small fraction reaches the
plasma membrane.
-!- SUBCELLULAR LOCATION: Envelope glycoprotein E2: Virion membrane
{ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.
Host endoplasmic reticulum membrane {ECO:0000250}; Single-pass
type I membrane protein {ECO:0000250}. Note=The C-terminal
transmembrane domain acts as a signal sequence and forms a hairpin
structure before cleavage by host signal peptidase. After
cleavage, the membrane sequence is retained at the C-terminus of
the protein, serving as ER membrane anchor. A reorientation of the
second hydrophobic stretch occurs after cleavage producing a
single reoriented transmembrane domain. These events explain the
final topology of the protein. ER retention of E2 is leaky and, in
overexpression conditions, only a small fraction reaches the
plasma membrane.
-!- SUBCELLULAR LOCATION: p7: Host endoplasmic reticulum membrane
{ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Host
cell membrane {ECO:0000250}. Note=The C-terminus of p7 membrane
domain acts as a signal sequence. After cleavage by host signal
peptidase, the membrane sequence is retained at the C-terminus of
the protein, serving as ER membrane anchor. Only a fraction
localizes to the plasma membrane.
-!- SUBCELLULAR LOCATION: Protease NS2-3: Host endoplasmic reticulum
membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
-!- SUBCELLULAR LOCATION: Serine protease NS3: Host endoplasmic
reticulum membrane {ECO:0000250}; Peripheral membrane protein
{ECO:0000250}. Note=NS3 is associated to the ER membrane through
its binding to NS4A.
-!- SUBCELLULAR LOCATION: Non-structural protein 4A: Host endoplasmic
reticulum membrane {ECO:0000305}; Single-pass type I membrane
protein {ECO:0000305}. Note=Host membrane insertion occurs after
processing by the NS3 protease.
-!- SUBCELLULAR LOCATION: Non-structural protein 4B: Host endoplasmic
reticulum membrane {ECO:0000250}; Multi-pass membrane protein
{ECO:0000250}.
-!- SUBCELLULAR LOCATION: Non-structural protein 5A: Host endoplasmic
reticulum membrane {ECO:0000250}; Peripheral membrane protein
{ECO:0000250}. Host cytoplasm, host perinuclear region
{ECO:0000250}. Host mitochondrion {ECO:0000250}. Note=Host
membrane insertion occurs after processing by the NS3 protease.
-!- SUBCELLULAR LOCATION: RNA-directed RNA polymerase: Host
endoplasmic reticulum membrane {ECO:0000305}; Single-pass type I
membrane protein {ECO:0000305}. Note=Host membrane insertion
occurs after processing by the NS3 protease.
-!- DOMAIN: The transmembrane regions of envelope E1 and E2
glycoproteins are involved in heterodimer formation, ER
localization, and assembly of these proteins. Envelope E2
glycoprotein contain two highly variable regions called
hypervariable region 1 and 2 (HVR1 and HVR2). E2 also contain two
segments involved in CD81-binding. HVR1 is implicated in the
SCARB1-mediated cell entry. HVR2 and CD81-binding regions may be
involved in sensitivity and/or resistance to IFN-alpha therapy (By
similarity). {ECO:0000250}.
-!- DOMAIN: The N-terminus of NS5A acts as membrane anchor. The
central part of NS5A contains a variable region called interferon
sensitivity determining region (ISDR) and seems to be
intrinsically disordered and interacts with NS5B and host PKR. The
C-terminus of NS5A contains a variable region called variable
region 3 (V3). ISDR and V3 may be involved in sensitivity and/or
resistance to IFN-alpha therapy (By similarity). {ECO:0000250}.
-!- DOMAIN: The SH3-binding domain of NS5A is involved in the
interaction with human Bin1, GRB2 and Src-family kinases.
{ECO:0000250}.
-!- DOMAIN: The N-terminal one-third of serine protease NS3 contains
the protease activity. This region contains a zinc atom that does
not belong to the active site, but may play a structural rather
than a catalytic role. This region is essential for the activity
of protease NS2-3, maybe by contributing to the folding of the
latter. The helicase activity is located in the C-terminus of NS3
(By similarity). {ECO:0000250}.
-!- PTM: Specific enzymatic cleavages in vivo yield mature proteins.
The structural proteins, core, E1, E2 and p7 are produced by
proteolytic processing by host signal peptidases. The core protein
is synthesized as a 21 kDa precursor which is retained in the ER
membrane through the hydrophobic signal peptide. Cleavage by the
signal peptidase releases the 19 kDa mature core protein. The
other proteins (p7, NS2-3, NS3, NS4A, NS4B, NS5A and NS5B) are
cleaved by the viral proteases (By similarity). {ECO:0000250}.
-!- PTM: Envelope E1 and E2 glycoproteins are highly N-glycosylated.
{ECO:0000250}.
-!- PTM: Core protein is phosphorylated by host PKC and PKA.
{ECO:0000250}.
-!- PTM: NS5A is phosphorylated in a basal form termed p56. p58 is a
hyperphosphorylated form of p56. p56 and p58 coexist in the cell
in roughly equivalent amounts. Hyperphosphorylation is dependent
on the presence of NS4A. Human AKT1, RPS6KB1/p70S6K, MAP2K1/MEK1,
MAP2K6/MKK6 and CSNK1A1/CKI-alpha kinases may be responsible for
NS5A phosphorylation (By similarity). {ECO:0000250}.
-!- PTM: NS4B is palmitoylated. This modification may play a role in
its polymerization or in protein-protein interactions (By
similarity). {ECO:0000250}.
-!- PTM: The N-terminus of a fraction of NS4B molecules seems to be
relocated post-translationally from the cytoplasm to the ER lumen,
with a 5th transmembrane segment. The C-terminus of NS2 may be
lumenal with a fourth transmembrane segment (By similarity).
{ECO:0000250}.
-!- PTM: Core protein is ubiquitinated; mediated by UBE3A and leading
to core protein subsequent proteasomal degradation. {ECO:0000250}.
-!- MISCELLANEOUS: Cell culture adaptation of the virus leads to
mutations in NS5A, reducing its inhibitory effect on replication.
{ECO:0000250}.
-!- MISCELLANEOUS: Core protein exerts viral interference on hepatitis
B virus when HCV and HBV coinfect the same cell, by suppressing
HBV gene expression, RNA encapsidation and budding. {ECO:0000250}.
-!- SIMILARITY: Belongs to the hepacivirus polyprotein family.
{ECO:0000305}.
-!- CAUTION: The core gene probably also codes for alternative reading
frame proteins (ARFPs). Many functions depicted for the core
protein might belong to the ARFPs. {ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AJ238799; CAB46677.1; -; Genomic_RNA.
PIR; A61196; A61196.
PIR; PQ0246; PQ0246.
PIR; PS0329; PS0329.
PDB; 1ZH1; X-ray; 2.50 A; A/B=2008-2170.
PDB; 2JY0; NMR; -; A=810-836.
PDB; 2KWT; NMR; -; A=836-868.
PDB; 2KWZ; NMR; -; A=869-908.
PDB; 3FQL; X-ray; 1.80 A; A=2421-2989.
PDB; 3FQM; X-ray; 1.90 A; A/B=2005-2174.
PDB; 3FQQ; X-ray; 2.20 A; A/B=2005-2174.
PDB; 3KN2; X-ray; 2.30 A; B/D=1678-1696.
PDB; 3KQH; X-ray; 2.40 A; A/B=1215-1650.
PDB; 3KQK; X-ray; 2.80 A; A/B=1215-1650.
PDB; 3KQL; X-ray; 2.50 A; A/B=1215-1650.
PDB; 3KQN; X-ray; 2.05 A; A=1215-1650.
PDB; 3KQU; X-ray; 2.40 A; A/B/C/D/E/F=1215-1650.
PDB; 3Q0Z; X-ray; 2.29 A; A/B=2420-2992.
PDB; 3QGD; X-ray; 2.60 A; A/B=2420-2992.
PDB; 3QGE; X-ray; 3.00 A; A/B=2420-2992.
PDB; 3QGF; X-ray; 2.45 A; A/B=2420-2992.
PDB; 3QGG; X-ray; 3.22 A; A/B=2420-2992.
PDB; 4NLD; X-ray; 2.75 A; A=2420-2992.
PDB; 4U01; X-ray; 2.80 A; A/B/C/D/E/F/G/H/J=1027-1206.
PDB; 5E4F; X-ray; 2.10 A; A/B=1215-1651.
PDB; 5PZK; X-ray; 2.20 A; A/B=2420-2992.
PDB; 5PZL; X-ray; 2.06 A; A/B=2420-2992.
PDB; 5PZM; X-ray; 2.54 A; A/B=2420-2992.
PDB; 5PZN; X-ray; 2.25 A; A/B=2420-2992.
PDB; 5PZO; X-ray; 2.80 A; A/B=2420-2992.
PDB; 5PZP; X-ray; 2.95 A; A/B=2420-2992.
PDB; 5TRH; X-ray; 2.70 A; A/B=2420-2992.
PDB; 5TRI; X-ray; 2.30 A; A/B=2420-2992.
PDB; 5TRJ; X-ray; 2.57 A; A/B=2420-2992.
PDB; 5TRK; X-ray; 2.06 A; A/B=2420-2992.
PDB; 5TWN; X-ray; 3.04 A; A/B=2420-2992.
PDBsum; 1ZH1; -.
PDBsum; 2JY0; -.
PDBsum; 2KWT; -.
PDBsum; 2KWZ; -.
PDBsum; 3FQL; -.
PDBsum; 3FQM; -.
PDBsum; 3FQQ; -.
PDBsum; 3KN2; -.
PDBsum; 3KQH; -.
PDBsum; 3KQK; -.
PDBsum; 3KQL; -.
PDBsum; 3KQN; -.
PDBsum; 3KQU; -.
PDBsum; 3Q0Z; -.
PDBsum; 3QGD; -.
PDBsum; 3QGE; -.
PDBsum; 3QGF; -.
PDBsum; 3QGG; -.
PDBsum; 4NLD; -.
PDBsum; 4U01; -.
PDBsum; 5E4F; -.
PDBsum; 5PZK; -.
PDBsum; 5PZL; -.
PDBsum; 5PZM; -.
PDBsum; 5PZN; -.
PDBsum; 5PZO; -.
PDBsum; 5PZP; -.
PDBsum; 5TRH; -.
PDBsum; 5TRI; -.
PDBsum; 5TRJ; -.
PDBsum; 5TRK; -.
PDBsum; 5TWN; -.
DisProt; DP00615; -.
ProteinModelPortal; Q9WMX2; -.
SMR; Q9WMX2; -.
IntAct; Q9WMX2; 450.
MINT; MINT-6548770; -.
BindingDB; Q9WMX2; -.
ChEMBL; CHEMBL5536; -.
DrugBank; DB07238; 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl)amino]-N-methyl-1-benzofuran-3-carboxamide.
iPTMnet; Q9WMX2; -.
euHCVdb; AJ238799; -.
OrthoDB; VOG090000UE; -.
EvolutionaryTrace; Q9WMX2; -.
Proteomes; UP000007414; Genome.
GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
GO; GO:0030430; C:host cell cytoplasm; IDA:AgBase.
GO; GO:0044165; C:host cell endoplasmic reticulum; IDA:AgBase.
GO; GO:0044167; C:host cell endoplasmic reticulum membrane; IDA:AgBase.
GO; GO:0044186; C:host cell lipid droplet; IEA:UniProtKB-SubCell.
GO; GO:0044191; C:host cell mitochondrial membrane; IEA:UniProtKB-SubCell.
GO; GO:0033650; C:host cell mitochondrion; IDA:AgBase.
GO; GO:0042025; C:host cell nucleus; IEA:UniProtKB-SubCell.
GO; GO:0044220; C:host cell perinuclear region of cytoplasm; IDA:AgBase.
GO; GO:0020002; C:host cell plasma membrane; IEA:UniProtKB-SubCell.
GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
GO; GO:0044385; C:integral to membrane of host cell; IEA:UniProtKB-KW.
GO; GO:0043234; C:protein complex; IMP:CAFA.
GO; GO:0019031; C:viral envelope; IEA:UniProtKB-KW.
GO; GO:0019013; C:viral nucleocapsid; IEA:UniProtKB-KW.
GO; GO:0055036; C:virion membrane; IEA:UniProtKB-SubCell.
GO; GO:0003779; F:actin binding; IPI:AgBase.
GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
GO; GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro.
GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro.
GO; GO:0005216; F:ion channel activity; IEA:UniProtKB-KW.
GO; GO:0042803; F:protein homodimerization activity; IMP:CAFA.
GO; GO:0003723; F:RNA binding; IDA:AgBase.
GO; GO:0003968; F:RNA-directed 5'-3' RNA polymerase activity; IDA:AgBase.
GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
GO; GO:0008270; F:zinc ion binding; IMP:CAFA.
GO; GO:0075520; P:actin-dependent intracellular transport of virus; IDA:AgBase.
GO; GO:0075512; P:clathrin-dependent endocytosis of virus by host cell; IEA:UniProtKB-KW.
GO; GO:0039654; P:fusion of virus membrane with host endosome membrane; IEA:UniProtKB-KW.
GO; GO:0039520; P:induction by virus of host autophagy; IEA:UniProtKB-KW.
GO; GO:0075519; P:microtubule-dependent intracellular transport of viral material; IDA:AgBase.
GO; GO:0039645; P:modulation by virus of host G1/S transition checkpoint; IEA:UniProtKB-KW.
GO; GO:0039707; P:pore formation by virus in membrane of host cell; IEA:UniProtKB-KW.
GO; GO:1990219; P:positive regulation by symbiont of host protein levels; IDA:AgBase.
GO; GO:0039690; P:positive stranded viral RNA replication; IMP:CAFA.
GO; GO:0051259; P:protein oligomerization; IEA:UniProtKB-KW.
GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
GO; GO:0039545; P:suppression by virus of host MAVS activity; IEA:UniProtKB-KW.
GO; GO:0039563; P:suppression by virus of host STAT1 activity; IEA:UniProtKB-KW.
GO; GO:0039547; P:suppression by virus of host TRAF activity; IEA:UniProtKB-KW.
GO; GO:0039502; P:suppression by virus of host type I interferon-mediated signaling pathway; IEA:UniProtKB-KW.
GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
GO; GO:0019087; P:transformation of host cell by virus; IEA:InterPro.
GO; GO:0039694; P:viral RNA genome replication; IMP:CAFA.
GO; GO:0019062; P:virion attachment to host cell; IEA:UniProtKB-KW.
CDD; cd00079; HELICc; 1.
InterPro; IPR011492; DEAD_Flavivir.
InterPro; IPR002521; HCV_core_C.
InterPro; IPR002522; HCV_core_N.
InterPro; IPR002519; HCV_env.
InterPro; IPR002531; HCV_NS1.
InterPro; IPR002518; HCV_NS2.
InterPro; IPR000745; HCV_NS4a.
InterPro; IPR001490; HCV_NS4b.
InterPro; IPR002868; HCV_NS5a.
InterPro; IPR013193; HCV_NS5a_1B_dom.
InterPro; IPR024350; HCV_NS5a_C.
InterPro; IPR014001; Helicase_ATP-bd.
InterPro; IPR001650; Helicase_C.
InterPro; IPR013192; NS5A_1a.
InterPro; IPR027417; P-loop_NTPase.
InterPro; IPR009003; Peptidase_S1_PA.
InterPro; IPR004109; Peptidase_S29_NS3.
InterPro; IPR007094; RNA-dir_pol_PSvirus.
InterPro; IPR002166; RNA_pol_HCV.
Pfam; PF07652; Flavi_DEAD; 1.
Pfam; PF01543; HCV_capsid; 1.
Pfam; PF01542; HCV_core; 1.
Pfam; PF01539; HCV_env; 1.
Pfam; PF01560; HCV_NS1; 1.
Pfam; PF01538; HCV_NS2; 1.
Pfam; PF01006; HCV_NS4a; 1.
Pfam; PF01001; HCV_NS4b; 1.
Pfam; PF01506; HCV_NS5a; 1.
Pfam; PF08300; HCV_NS5a_1a; 1.
Pfam; PF08301; HCV_NS5a_1b; 1.
Pfam; PF12941; HCV_NS5a_C; 1.
Pfam; PF02907; Peptidase_S29; 1.
Pfam; PF00998; RdRP_3; 1.
ProDom; PD001388; HCV_env; 1.
SMART; SM00487; DEXDc; 1.
SUPFAM; SSF50494; SSF50494; 1.
SUPFAM; SSF52540; SSF52540; 2.
PROSITE; PS51693; HCV_NS2_PRO; 1.
PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
PROSITE; PS51822; HV_PV_NS3_PRO; 1.
PROSITE; PS50507; RDRP_SSRNA_POS; 1.
1: Evidence at protein level;
3D-structure; Acetylation; Activation of host autophagy by virus;
Apoptosis; ATP-binding; Capsid protein;
Clathrin-mediated endocytosis of virus by host; Complete proteome;
Disulfide bond; Fusion of virus membrane with host endosomal membrane;
Fusion of virus membrane with host membrane;
G1/S host cell cycle checkpoint dysregulation by virus; Glycoprotein;
Helicase; Host cell membrane; Host cytoplasm;
Host endoplasmic reticulum; Host lipid droplet; Host membrane;
Host mitochondrion; Host nucleus; Host-virus interaction; Hydrolase;
Inhibition of host innate immune response by virus;
Inhibition of host interferon signaling pathway by virus;
Inhibition of host MAVS by virus;
Inhibition of host RLR pathway by virus;
Inhibition of host STAT1 by virus; Inhibition of host TRAFs by virus;
Interferon antiviral system evasion; Ion channel; Ion transport;
Lipoprotein; Membrane; Metal-binding;
Modulation of host cell cycle by virus; Multifunctional enzyme;
Nucleotide-binding; Nucleotidyltransferase; Oncogene; Palmitate;
Phosphoprotein; Protease; Ribonucleoprotein; RNA-binding;
RNA-directed RNA polymerase; Secreted; Serine protease; SH3-binding;
Thiol protease; Transcription; Transcription regulation; Transferase;
Transmembrane; Transmembrane helix; Transport; Ubl conjugation;
Viral attachment to host cell; Viral envelope protein;
Viral immunoevasion; Viral ion channel; Viral nucleoprotein;
Viral penetration into host cytoplasm; Viral RNA replication; Virion;
Virus endocytosis by host; Virus entry into host cell; Zinc.
INIT_MET 1 1 Removed; by host. {ECO:0000250}.
CHAIN 2 191 Core protein p21. {ECO:0000255}.
/FTId=PRO_0000037541.
CHAIN 2 177 Core protein p19. {ECO:0000250}.
/FTId=PRO_0000037542.
PROPEP 178 191 ER anchor for the core protein, removed
in mature form by host signal peptidase.
{ECO:0000250}.
/FTId=PRO_0000037543.
CHAIN 192 383 Envelope glycoprotein E1. {ECO:0000255}.
/FTId=PRO_0000037544.
CHAIN 384 746 Envelope glycoprotein E2. {ECO:0000255}.
/FTId=PRO_0000037545.
CHAIN 747 809 p7. {ECO:0000250}.
/FTId=PRO_0000037546.
CHAIN 810 1026 Protease NS2-3. {ECO:0000255|PROSITE-
ProRule:PRU01030}.
/FTId=PRO_0000037547.
CHAIN 1027 1657 Serine protease NS3. {ECO:0000255}.
/FTId=PRO_0000037548.
CHAIN 1658 1711 Non-structural protein 4A. {ECO:0000255}.
/FTId=PRO_0000037549.
CHAIN 1712 1972 Non-structural protein 4B. {ECO:0000255}.
/FTId=PRO_0000037550.
CHAIN 1973 2419 Non-structural protein 5A. {ECO:0000255}.
/FTId=PRO_0000037551.
CHAIN 2420 3010 RNA-directed RNA polymerase.
{ECO:0000255}.
/FTId=PRO_0000037552.
TOPO_DOM 2 168 Cytoplasmic. {ECO:0000255}.
TRANSMEM 169 189 Helical. {ECO:0000255}.
TOPO_DOM 190 358 Lumenal. {ECO:0000255}.
TRANSMEM 359 379 Helical. {ECO:0000255}.
TOPO_DOM 380 725 Lumenal. {ECO:0000255}.
TRANSMEM 726 746 Helical. {ECO:0000255}.
TOPO_DOM 747 757 Lumenal. {ECO:0000255}.
TRANSMEM 758 778 Helical. {ECO:0000255}.
TOPO_DOM 779 782 Cytoplasmic. {ECO:0000255}.
TRANSMEM 783 803 Helical. {ECO:0000255}.
TOPO_DOM 804 813 Lumenal. {ECO:0000255}.
TRANSMEM 814 834 Helical. {ECO:0000255}.
TOPO_DOM 835 881 Cytoplasmic. {ECO:0000255}.
TRANSMEM 882 902 Helical. {ECO:0000255}.
TOPO_DOM 903 928 Lumenal. {ECO:0000255}.
TRANSMEM 929 949 Helical. {ECO:0000255}.
TOPO_DOM 950 1657 Cytoplasmic. {ECO:0000255}.
TRANSMEM 1658 1678 Helical. {ECO:0000255}.
TOPO_DOM 1679 1805 Cytoplasmic. {ECO:0000255}.
TRANSMEM 1806 1826 Helical. {ECO:0000255}.
TOPO_DOM 1827 1828 Lumenal. {ECO:0000255}.
TRANSMEM 1829 1849 Helical. {ECO:0000255}.
TOPO_DOM 1850 1850 Cytoplasmic. {ECO:0000255}.
TRANSMEM 1851 1871 Helical. {ECO:0000255}.
TOPO_DOM 1872 1881 Lumenal. {ECO:0000255}.
TRANSMEM 1882 1902 Helical. {ECO:0000255}.
TOPO_DOM 1903 1972 Cytoplasmic. {ECO:0000255}.
INTRAMEM 1973 2002 {ECO:0000250}.
TOPO_DOM 2003 2989 Cytoplasmic. {ECO:0000255}.
TRANSMEM 2990 3010 Helical. {ECO:0000250}.
DOMAIN 903 1026 Peptidase C18. {ECO:0000255|PROSITE-
ProRule:PRU01030}.
DOMAIN 1027 1208 Peptidase S29. {ECO:0000255|PROSITE-
ProRule:PRU01166}.
DOMAIN 1217 1369 Helicase ATP-binding.
{ECO:0000255|PROSITE-ProRule:PRU00541}.
DOMAIN 2633 2751 RdRp catalytic. {ECO:0000255|PROSITE-
ProRule:PRU00539}.
NP_BIND 1230 1237 ATP. {ECO:0000255|PROSITE-
ProRule:PRU00541}.
REGION 2 59 Interaction with DDX3X. {ECO:0000250}.
REGION 2 23 Interaction with STAT1. {ECO:0000250}.
REGION 122 173 Interaction with APOA2. {ECO:0000250}.
REGION 150 159 Mitochondrial targeting signal.
{ECO:0000250}.
REGION 164 167 Important for lipid droplets
localization. {ECO:0000250}.
REGION 265 296 Fusion peptide. {ECO:0000255}.
REGION 385 411 HVR1. {ECO:0000250}.
REGION 475 481 HVR2. {ECO:0000250}.
REGION 482 494 CD81-binding 1. {ECO:0000255}.
REGION 522 553 CD81-binding 2. {ECO:0000255}.
REGION 660 671 PKR/eIF2-alpha phosphorylation homology
domain (PePHD). {ECO:0000250}.
REGION 1679 1690 NS3-binding (by NS4A). {ECO:0000255}.
REGION 2120 2332 Transcriptional activation.
{ECO:0000255}.
REGION 2120 2208 FKBP8-binding. {ECO:0000255}.
REGION 2200 2250 Basal phosphorylation. {ECO:0000250}.
REGION 2210 2275 PKR-binding. {ECO:0000255}.
REGION 2210 2249 ISDR. {ECO:0000250}.
REGION 2249 2306 NS4B-binding. {ECO:0000255}.
REGION 2351 2419 Basal phosphorylation. {ECO:0000250}.
REGION 2354 2377 V3. {ECO:0000250}.
MOTIF 5 13 Nuclear localization signal.
{ECO:0000255}.
MOTIF 38 43 Nuclear localization signal.
{ECO:0000255}.
MOTIF 58 64 Nuclear localization signal.
{ECO:0000255}.
MOTIF 66 71 Nuclear localization signal.
{ECO:0000255}.
MOTIF 1316 1319 DECH box.
MOTIF 2322 2325 SH3-binding. {ECO:0000255}.
MOTIF 2327 2335 Nuclear localization signal.
{ECO:0000255}.
COMPBIAS 796 803 Poly-Leu.
COMPBIAS 2282 2327 Pro-rich.
COMPBIAS 2718 2721 Poly-Ala.
COMPBIAS 2995 2998 Poly-Leu.
ACT_SITE 952 952 For protease NS2-3 activity; shared with
dimeric partner. {ECO:0000255|PROSITE-
ProRule:PRU01030}.
ACT_SITE 972 972 For protease NS2-3 activity; shared with
dimeric partner. {ECO:0000255|PROSITE-
ProRule:PRU01030}.
ACT_SITE 993 993 For protease NS2-3 activity; shared with
dimeric partner. {ECO:0000255|PROSITE-
ProRule:PRU01030}.
ACT_SITE 1083 1083 Charge relay system; for serine protease
NS3 activity. {ECO:0000255|PROSITE-
ProRule:PRU01166}.
ACT_SITE 1107 1107 Charge relay system; for serine protease
NS3 activity. {ECO:0000255|PROSITE-
ProRule:PRU01166}.
ACT_SITE 1165 1165 Charge relay system; for serine protease
NS3 activity. {ECO:0000255|PROSITE-
ProRule:PRU01166}.
METAL 1123 1123 Zinc. {ECO:0000255|PROSITE-
ProRule:PRU01166}.
METAL 1125 1125 Zinc. {ECO:0000255|PROSITE-
ProRule:PRU01166}.
METAL 1171 1171 Zinc. {ECO:0000255|PROSITE-
ProRule:PRU01166}.
METAL 1175 1175 Zinc. {ECO:0000255|PROSITE-
ProRule:PRU01166}.
METAL 2011 2011 Zinc. {ECO:0000269|PubMed:19244328}.
METAL 2029 2029 Zinc. {ECO:0000269|PubMed:19244328}.
METAL 2031 2031 Zinc. {ECO:0000269|PubMed:19244328}.
METAL 2052 2052 Zinc. {ECO:0000269|PubMed:19244328}.
SITE 177 178 Cleavage; by host signal peptidase.
{ECO:0000250}.
SITE 191 192 Cleavage; by host signal peptidase.
{ECO:0000255}.
SITE 383 384 Cleavage; by host signal peptidase.
{ECO:0000250}.
SITE 746 747 Cleavage; by host signal peptidase.
{ECO:0000250}.
SITE 809 810 Cleavage; by host signal peptidase.
{ECO:0000250}.
SITE 1026 1027 Cleavage; by protease NS2-3.
{ECO:0000255|PROSITE-ProRule:PRU01030}.
SITE 1657 1658 Cleavage; by serine protease NS3.
{ECO:0000255}.
SITE 1711 1712 Cleavage; by serine protease NS3.
{ECO:0000255}.
SITE 1972 1973 Cleavage; by serine protease NS3.
{ECO:0000255}.
SITE 2419 2420 Cleavage; by serine protease NS3.
{ECO:0000255}.
MOD_RES 2 2 N-acetylserine; by host. {ECO:0000250}.
MOD_RES 53 53 Phosphoserine; by host. {ECO:0000250}.
MOD_RES 99 99 Phosphoserine; by host. {ECO:0000250}.
MOD_RES 116 116 Phosphoserine; by host PKA.
{ECO:0000250}.
MOD_RES 2194 2194 Phosphoserine; by host; in p56.
{ECO:0000269|PubMed:15709040}.
MOD_RES 2197 2197 Phosphoserine; by host; in p58.
{ECO:0000269|PubMed:15709040}.
MOD_RES 2201 2201 Phosphoserine; by host; in p58.
{ECO:0000269|PubMed:15709040}.
MOD_RES 2204 2204 Phosphoserine; by host; in p58.
{ECO:0000269|PubMed:15709040}.
LIPID 1968 1968 S-palmitoyl cysteine; by host.
{ECO:0000250}.
LIPID 1972 1972 S-palmitoyl cysteine; by host.
{ECO:0000250}.
CARBOHYD 196 196 N-linked (GlcNAc...) asparagine; by host.
{ECO:0000255}.
CARBOHYD 209 209 N-linked (GlcNAc...) asparagine; by host.
{ECO:0000255}.
CARBOHYD 234 234 N-linked (GlcNAc...) asparagine; by host.
{ECO:0000255}.
CARBOHYD 250 250 N-linked (GlcNAc...) asparagine; by host.
{ECO:0000255}.
CARBOHYD 305 305 N-linked (GlcNAc...) asparagine; by host.
{ECO:0000255}.
CARBOHYD 417 417 N-linked (GlcNAc...) asparagine; by host.
{ECO:0000255}.
CARBOHYD 423 423 N-linked (GlcNAc...) asparagine; by host.
{ECO:0000255}.
CARBOHYD 430 430 N-linked (GlcNAc...) asparagine; by host.
{ECO:0000255}.
CARBOHYD 448 448 N-linked (GlcNAc...) asparagine; by host.
{ECO:0000255}.
CARBOHYD 532 532 N-linked (GlcNAc...) asparagine; by host.
{ECO:0000255}.
CARBOHYD 556 556 N-linked (GlcNAc...) asparagine; by host.
{ECO:0000255}.
CARBOHYD 576 576 N-linked (GlcNAc...) asparagine; by host.
{ECO:0000255}.
CARBOHYD 623 623 N-linked (GlcNAc...) asparagine; by host.
{ECO:0000255}.
CARBOHYD 645 645 N-linked (GlcNAc...) asparagine; by host.
{ECO:0000255}.
DISULFID 2114 2162 {ECO:0000305|PubMed:15902263}.
VARIANT 2204 2204 S -> I.
MUTAGEN 2158 2158 S->A: No effect on replication.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2173 2173 S->A: No effect on replication.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2179 2179 S->A: No effect on replication.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2194 2194 S->A: No effect on replication. No effect
on NS5A hyperphosphorylation.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2194 2194 S->E: No effect on replication. No effect
on NS5A hyperphosphorylation.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2197 2197 S->A: Enhanced replication. Decreased
NS5A hyperphosphorylation.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2197 2197 S->E: No effect on replication. Decreased
NS5A hyperphosphorylation.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2200 2200 S->A: No effect on replication. Decreased
NS5A hyperphosphorylation.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2200 2200 S->E: No effect on replication. Decreased
NS5A hyperphosphorylation.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2201 2201 S->A: Enhanced replication. Decreased
NS5A hyperphosphorylation.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2201 2201 S->E: Enhanced replication. Decreased
NS5A hyperphosphorylation.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2202 2202 S->A: Enhanced replication.No effect on
NS5A hyperphosphorylation.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2202 2202 S->E: No effect on replication. Decreased
NS5A hyperphosphorylation.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2204 2204 S->A: Enhanced replication. Decreased
NS5A hyperphosphorylation.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2204 2204 S->E: No effect on replication. No effect
on NS5A hyperphosphorylation.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2207 2207 S->A: Enhanced replication. No effect on
hyperphosphorylation.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2207 2207 S->E: No effect on replication.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2210 2210 S->A: No effect on replication. No effect
on hyperphosphorylation.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2210 2210 S->E: No effect on replication. No effect
on hyperphosphorylation.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2221 2221 S->A: No effect on hyperphosphorylation.
MUTAGEN 2246 2246 S->A: No effect on replication.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2255 2255 S->A: No effect on replication.
{ECO:0000269|PubMed:15709040}.
MUTAGEN 2269 2269 S->A: No effect on replication.
{ECO:0000269|PubMed:15709040}.
HELIX 843 857 {ECO:0000244|PDB:2KWT}.
HELIX 873 879 {ECO:0000244|PDB:2KWZ}.
HELIX 882 894 {ECO:0000244|PDB:2KWZ}.
HELIX 898 901 {ECO:0000244|PDB:2KWZ}.
TURN 902 905 {ECO:0000244|PDB:2KWZ}.
STRAND 1030 1035 {ECO:0000244|PDB:4U01}.
HELIX 1039 1048 {ECO:0000244|PDB:4U01}.
STRAND 1057 1063 {ECO:0000244|PDB:4U01}.
STRAND 1068 1074 {ECO:0000244|PDB:4U01}.
STRAND 1077 1081 {ECO:0000244|PDB:4U01}.
HELIX 1082 1085 {ECO:0000244|PDB:4U01}.
STRAND 1100 1103 {ECO:0000244|PDB:4U01}.
HELIX 1104 1106 {ECO:0000244|PDB:4U01}.
STRAND 1108 1112 {ECO:0000244|PDB:4U01}.
STRAND 1128 1133 {ECO:0000244|PDB:4U01}.
STRAND 1139 1144 {ECO:0000244|PDB:4U01}.
STRAND 1146 1158 {ECO:0000244|PDB:4U01}.
TURN 1159 1163 {ECO:0000244|PDB:4U01}.
STRAND 1168 1170 {ECO:0000244|PDB:4U01}.
STRAND 1176 1186 {ECO:0000244|PDB:4U01}.
STRAND 1189 1197 {ECO:0000244|PDB:4U01}.
HELIX 1198 1204 {ECO:0000244|PDB:4U01}.
STRAND 1224 1229 {ECO:0000244|PDB:3KQN}.
TURN 1236 1238 {ECO:0000244|PDB:3KQN}.
HELIX 1239 1246 {ECO:0000244|PDB:3KQN}.
STRAND 1251 1256 {ECO:0000244|PDB:3KQN}.
HELIX 1258 1271 {ECO:0000244|PDB:3KQN}.
STRAND 1277 1279 {ECO:0000244|PDB:3KQN}.
STRAND 1290 1295 {ECO:0000244|PDB:3KQN}.
HELIX 1296 1301 {ECO:0000244|PDB:3KQN}.
STRAND 1311 1315 {ECO:0000244|PDB:3KQN}.
TURN 1316 1319 {ECO:0000244|PDB:3KQN}.
HELIX 1323 1335 {ECO:0000244|PDB:3KQN}.
TURN 1336 1340 {ECO:0000244|PDB:3KQN}.
STRAND 1342 1350 {ECO:0000244|PDB:3KQN}.
STRAND 1362 1366 {ECO:0000244|PDB:3KQN}.
STRAND 1371 1375 {ECO:0000244|PDB:3KQN}.
STRAND 1378 1380 {ECO:0000244|PDB:3KQN}.
HELIX 1382 1384 {ECO:0000244|PDB:3KQN}.
STRAND 1386 1393 {ECO:0000244|PDB:3KQN}.
HELIX 1397 1409 {ECO:0000244|PDB:3KQN}.
STRAND 1414 1417 {ECO:0000244|PDB:3KQN}.
HELIX 1423 1425 {ECO:0000244|PDB:3KQN}.
STRAND 1428 1436 {ECO:0000244|PDB:3KQN}.
HELIX 1438 1440 {ECO:0000244|PDB:3KQN}.
STRAND 1441 1443 {ECO:0000244|PDB:3KQN}.
STRAND 1448 1453 {ECO:0000244|PDB:3KQN}.
STRAND 1456 1463 {ECO:0000244|PDB:3KQN}.
STRAND 1467 1469 {ECO:0000244|PDB:3KQN}.
STRAND 1471 1478 {ECO:0000244|PDB:3KQN}.
HELIX 1481 1488 {ECO:0000244|PDB:3KQN}.
STRAND 1493 1495 {ECO:0000244|PDB:3KQN}.
STRAND 1497 1503 {ECO:0000244|PDB:3KQN}.
STRAND 1509 1511 {ECO:0000244|PDB:3KQH}.
HELIX 1514 1526 {ECO:0000244|PDB:3KQN}.
HELIX 1532 1543 {ECO:0000244|PDB:3KQN}.
HELIX 1555 1563 {ECO:0000244|PDB:3KQN}.
HELIX 1570 1579 {ECO:0000244|PDB:3KQN}.
HELIX 1584 1597 {ECO:0000244|PDB:3KQN}.
HELIX 1606 1617 {ECO:0000244|PDB:3KQN}.
STRAND 1626 1629 {ECO:0000244|PDB:3KQN}.
HELIX 1640 1648 {ECO:0000244|PDB:3KQN}.
STRAND 1680 1689 {ECO:0000244|PDB:3KN2}.
TURN 2007 2009 {ECO:0000244|PDB:3FQM}.
STRAND 2017 2021 {ECO:0000244|PDB:3FQM}.
STRAND 2023 2028 {ECO:0000244|PDB:3FQM}.
STRAND 2034 2040 {ECO:0000244|PDB:3FQM}.
STRAND 2043 2047 {ECO:0000244|PDB:3FQM}.
HELIX 2053 2057 {ECO:0000244|PDB:3FQM}.
STRAND 2067 2069 {ECO:0000244|PDB:3FQM}.
STRAND 2071 2073 {ECO:0000244|PDB:3FQM}.
STRAND 2079 2086 {ECO:0000244|PDB:3FQM}.
STRAND 2089 2096 {ECO:0000244|PDB:3FQM}.
STRAND 2099 2107 {ECO:0000244|PDB:3FQM}.
HELIX 2119 2121 {ECO:0000244|PDB:3FQM}.
STRAND 2123 2125 {ECO:0000244|PDB:3FQM}.
STRAND 2146 2149 {ECO:0000244|PDB:3FQM}.
STRAND 2152 2155 {ECO:0000244|PDB:3FQM}.
STRAND 2421 2425 {ECO:0000244|PDB:3FQL}.
HELIX 2444 2447 {ECO:0000244|PDB:3FQL}.
HELIX 2453 2455 {ECO:0000244|PDB:3FQL}.
STRAND 2456 2458 {ECO:0000244|PDB:3FQL}.
HELIX 2461 2463 {ECO:0000244|PDB:3FQL}.
HELIX 2464 2471 {ECO:0000244|PDB:3FQL}.
HELIX 2481 2494 {ECO:0000244|PDB:3FQL}.
HELIX 2504 2509 {ECO:0000244|PDB:3FQL}.
TURN 2519 2521 {ECO:0000244|PDB:3QGF}.
HELIX 2524 2528 {ECO:0000244|PDB:3FQL}.
HELIX 2532 2547 {ECO:0000244|PDB:3FQL}.
STRAND 2549 2551 {ECO:0000244|PDB:3FQL}.
STRAND 2555 2559 {ECO:0000244|PDB:3FQL}.
STRAND 2563 2565 {ECO:0000244|PDB:3FQL}.
STRAND 2568 2570 {ECO:0000244|PDB:5TRI}.
STRAND 2578 2581 {ECO:0000244|PDB:3FQL}.
HELIX 2584 2606 {ECO:0000244|PDB:3FQL}.
HELIX 2607 2609 {ECO:0000244|PDB:3FQL}.
HELIX 2611 2613 {ECO:0000244|PDB:3FQL}.
HELIX 2616 2629 {ECO:0000244|PDB:3FQL}.
STRAND 2630 2640 {ECO:0000244|PDB:3FQL}.
HELIX 2643 2646 {ECO:0000244|PDB:3FQL}.
HELIX 2649 2659 {ECO:0000244|PDB:3FQL}.
HELIX 2666 2678 {ECO:0000244|PDB:3FQL}.
TURN 2679 2681 {ECO:0000244|PDB:4NLD}.
STRAND 2683 2686 {ECO:0000244|PDB:3FQL}.
STRAND 2688 2690 {ECO:0000244|PDB:3QGG}.
STRAND 2692 2696 {ECO:0000244|PDB:3FQL}.
HELIX 2706 2725 {ECO:0000244|PDB:3FQL}.
STRAND 2728 2735 {ECO:0000244|PDB:3FQL}.
STRAND 2738 2744 {ECO:0000244|PDB:3FQL}.
HELIX 2748 2764 {ECO:0000244|PDB:3FQL}.
STRAND 2769 2771 {ECO:0000244|PDB:3FQL}.
STRAND 2776 2778 {ECO:0000244|PDB:3FQL}.
HELIX 2779 2781 {ECO:0000244|PDB:3FQL}.
STRAND 2787 2793 {ECO:0000244|PDB:3FQL}.
STRAND 2799 2804 {ECO:0000244|PDB:3FQL}.
HELIX 2808 2819 {ECO:0000244|PDB:3FQL}.
HELIX 2826 2833 {ECO:0000244|PDB:3FQL}.
TURN 2834 2836 {ECO:0000244|PDB:3FQL}.
HELIX 2838 2842 {ECO:0000244|PDB:3FQL}.
HELIX 2844 2855 {ECO:0000244|PDB:3FQL}.
STRAND 2858 2860 {ECO:0000244|PDB:4NLD}.
STRAND 2862 2866 {ECO:0000244|PDB:3FQL}.
STRAND 2869 2873 {ECO:0000244|PDB:3FQL}.
HELIX 2875 2877 {ECO:0000244|PDB:3FQL}.
HELIX 2878 2886 {ECO:0000244|PDB:3FQL}.
HELIX 2888 2891 {ECO:0000244|PDB:3FQL}.
HELIX 2898 2911 {ECO:0000244|PDB:3FQL}.
HELIX 2916 2932 {ECO:0000244|PDB:3FQL}.
HELIX 2935 2944 {ECO:0000244|PDB:3FQL}.
HELIX 2946 2948 {ECO:0000244|PDB:3FQL}.
STRAND 2949 2951 {ECO:0000244|PDB:5TRK}.
HELIX 2959 2963 {ECO:0000244|PDB:3FQL}.
TURN 2967 2970 {ECO:0000244|PDB:5TRK}.
TURN 2974 2976 {ECO:0000244|PDB:3FQL}.
STRAND 2980 2982 {ECO:0000244|PDB:3FQL}.
STRAND 2984 2987 {ECO:0000244|PDB:3Q0Z}.
SEQUENCE 3010 AA; 326906 MW; 37B3448DAFA9A10B CRC64;
MSTNPKPQRK TKRNTNRRPQ DVKFPGGGQI VGGVYLLPRR GPRLGVRATR KTSERSQPRG
RRQPIPKARQ PEGRAWAQPG YPWPLYGNEG LGWAGWLLSP RGSRPSWGPT DPRRRSRNLG
KVIDTLTCGF ADLMGYIPLV GAPLGGAARA LAHGVRVLED GVNYATGNLP GCSFSIFLLA
LLSCLTIPAS AYEVRNVSGV YHVTNDCSNA SIVYEAADMI MHTPGCVPCV RENNSSRCWV
ALTPTLAARN ASVPTTTIRR HVDLLVGAAA LCSAMYVGDL CGSVFLVAQL FTFSPRRHET
VQDCNCSIYP GHVTGHRMAW DMMMNWSPTA ALVVSQLLRI PQAVVDMVAG AHWGVLAGLA
YYSMVGNWAK VLIVMLLFAG VDGGTYVTGG TMAKNTLGIT SLFSPGSSQK IQLVNTNGSW
HINRTALNCN DSLNTGFLAA LFYVHKFNSS GCPERMASCS PIDAFAQGWG PITYNESHSS
DQRPYCWHYA PRPCGIVPAA QVCGPVYCFT PSPVVVGTTD RFGVPTYSWG ENETDVLLLN
NTRPPQGNWF GCTWMNSTGF TKTCGGPPCN IGGIGNKTLT CPTDCFRKHP EATYTKCGSG
PWLTPRCLVH YPYRLWHYPC TVNFTIFKVR MYVGGVEHRL EAACNWTRGE RCNLEDRDRS
ELSPLLLSTT EWQVLPCSFT TLPALSTGLI HLHQNVVDVQ YLYGIGSAVV SFAIKWEYVL
LLFLLLADAR VCACLWMMLL IAQAEAALEN LVVLNAASVA GAHGILSFLV FFCAAWYIKG
RLVPGAAYAL YGVWPLLLLL LALPPRAYAM DREMAASCGG AVFVGLILLT LSPHYKLFLA
RLIWWLQYFI TRAEAHLQVW IPPLNVRGGR DAVILLTCAI HPELIFTITK ILLAILGPLM
VLQAGITKVP YFVRAHGLIR ACMLVRKVAG GHYVQMALMK LAALTGTYVY DHLTPLRDWA
HAGLRDLAVA VEPVVFSDME TKVITWGADT AACGDIILGL PVSARRGREI HLGPADSLEG
QGWRLLAPIT AYSQQTRGLL GCIITSLTGR DRNQVEGEVQ VVSTATQSFL ATCVNGVCWT
VYHGAGSKTL AGPKGPITQM YTNVDQDLVG WQAPPGARSL TPCTCGSSDL YLVTRHADVI
PVRRRGDSRG SLLSPRPVSY LKGSSGGPLL CPSGHAVGIF RAAVCTRGVA KAVDFVPVES
METTMRSPVF TDNSSPPAVP QTFQVAHLHA PTGSGKSTKV PAAYAAQGYK VLVLNPSVAA
TLGFGAYMSK AHGIDPNIRT GVRTITTGAP ITYSTYGKFL ADGGCSGGAY DIIICDECHS
TDSTTILGIG TVLDQAETAG ARLVVLATAT PPGSVTVPHP NIEEVALSST GEIPFYGKAI
PIETIKGGRH LIFCHSKKKC DELAAKLSGL GLNAVAYYRG LDVSVIPTSG DVIVVATDAL
MTGFTGDFDS VIDCNTCVTQ TVDFSLDPTF TIETTTVPQD AVSRSQRRGR TGRGRMGIYR
FVTPGERPSG MFDSSVLCEC YDAGCAWYEL TPAETSVRLR AYLNTPGLPV CQDHLEFWES
VFTGLTHIDA HFLSQTKQAG DNFPYLVAYQ ATVCARAQAP PPSWDQMWKC LIRLKPTLHG
PTPLLYRLGA VQNEVTTTHP ITKYIMACMS ADLEVVTSTW VLVGGVLAAL AAYCLTTGSV
VIVGRIILSG KPAIIPDREV LYREFDEMEE CASHLPYIEQ GMQLAEQFKQ KAIGLLQTAT
KQAEAAAPVV ESKWRTLEAF WAKHMWNFIS GIQYLAGLST LPGNPAIASL MAFTASITSP
LTTQHTLLFN ILGGWVAAQL APPSAASAFV GAGIAGAAVG SIGLGKVLVD ILAGYGAGVA
GALVAFKVMS GEMPSTEDLV NLLPAILSPG ALVVGVVCAA ILRRHVGPGE GAVQWMNRLI
AFASRGNHVS PTHYVPESDA AARVTQILSS LTITQLLKRL HQWINEDCST PCSGSWLRDV
WDWICTVLTD FKTWLQSKLL PRLPGVPFFS CQRGYKGVWR GDGIMQTTCP CGAQITGHVK
NGSMRIVGPR TCSNTWHGTF PINAYTTGPC TPSPAPNYSR ALWRVAAEEY VEVTRVGDFH
YVTGMTTDNV KCPCQVPAPE FFTEVDGVRL HRYAPACKPL LREEVTFLVG LNQYLVGSQL
PCEPEPDVAV LTSMLTDPSH ITAETAKRRL ARGSPPSLAS SSASQLSAPS LKATCTTRHD
SPDADLIEAN LLWRQEMGGN ITRVESENKV VILDSFEPLQ AEEDEREVSV PAEILRRSRK
FPRAMPIWAR PDYNPPLLES WKDPDYVPPV VHGCPLPPAK APPIPPPRRK RTVVLSESTV
SSALAELATK TFGSSESSAV DSGTATASPD QPSDDGDAGS DVESYSSMPP LEGEPGDPDL
SDGSWSTVSE EASEDVVCCS MSYTWTGALI TPCAAEETKL PINALSNSLL RHHNLVYATT
SRSASLRQKK VTFDRLQVLD DHYRDVLKEM KAKASTVKAK LLSVEEACKL TPPHSARSKF
GYGAKDVRNL SSKAVNHIRS VWKDLLEDTE TPIDTTIMAK NEVFCVQPEK GGRKPARLIV
FPDLGVRVCE KMALYDVVST LPQAVMGSSY GFQYSPGQRV EFLVNAWKAK KCPMGFAYDT
RCFDSTVTEN DIRVEESIYQ CCDLAPEARQ AIRSLTERLY IGGPLTNSKG QNCGYRRCRA
SGVLTTSCGN TLTCYLKAAA ACRAAKLQDC TMLVCGDDLV VICESAGTQE DEASLRAFTE
AMTRYSAPPG DPPKPEYDLE LITSCSSNVS VAHDASGKRV YYLTRDPTTP LARAAWETAR
HTPVNSWLGN IIMYAPTLWA RMILMTHFFS ILLAQEQLEK ALDCQIYGAC YSIEPLDLPQ
IIQRLHGLSA FSLHSYSPGE INRVASCLRK LGVPPLRVWR HRARSVRARL LSQGGRAATC
GKYLFNWAVR TKLKLTPIPA ASQLDLSSWF VAGYSGGDIY HSLSRARPRW FMWCLLLLSV
GVGIYLLPNR


Related products :

Catalog number Product name Quantity
orb81767 Measles Virus Non-Structural C-Protein (1-51) protein The E.coli derived recombinant protein contains the Non-Structural C-Protein immunodominant regions, 1-51 amino acids. For research use only. 100
EIAAB12958 Envelope polyprotein,EnvK2 protein,ERVK6,HERV-K(C7) envelope protein,HERV-K(HML-2.HOM) envelope protein,HERV-K_7p22.1 provirus ancestral Env polyprotein,HERV-K108 envelope protein,Homo sapiens,Human
10-663-45517 Measles Virus Non-Structural C-Protein (MEVNSCP) - Protein P; Non-structural protein C. 38 kDa_29 kDa N_A 1 mg
10-663-45517 Measles Virus Non-Structural C-Protein (MEVNSCP) - Protein P; Non-structural protein C. 38 kDa_29 kDa N_A 0.5 mg
10-663-45517 Measles Virus Non-Structural C-Protein (MEVNSCP) - Protein P; Non-structural protein C. 38 kDa_29 kDa N_A 0.1 mg
EIAAB13002 Envelope polyprotein,ERV3,ERV3 envelope protein,ERV-3 envelope protein,ERV3-1,ERV3-1 envelope protein,ERV-R envelope protein,HERV-R envelope protein,HERV-R_7q21.2 provirus ancestral Env polyprotein,Ho
EIAAB13041 Endogenous retrovirus group W member 1,Envelope polyprotein gPr73,Enverin,Env-W,ERVW-1,ERVWE1,HERV-7q Envelope protein,HERV-W envelope protein,HERV-W_7q21.2 provirus ancestral Env polyprotein,Homo sap
MCA4688 MOUSE ANTI INFLUENZA A NON STRUCTURAL PROTEIN , Product Type Monoclonal Antibody, Specificity INFLUENZA A NON STRUCTURAL PROTEIN, Target Species Viral, Host Mouse, Format Purified, Isotypes IgG2 0.2 mg
SCH-MCA4688 MOUSE ANTI INFLUENZA A NON STRUCTURAL PROTEIN , Product Type Monoclonal Antibody, Specificity INFLUENZA A NON STRUCTURAL PROTEIN, Target Species Viral, Host Mouse, Format Purified, Isotypes IgG2 0.2 mg
25-030 ZC3H7B is a protein that contains a tetratricopeptide repeat domain. The encoded protein also interacts with the rotavirus non-structural protein NSP3. This gene encodes a protein that contains a tetr 0.05 mg
10-663-45516 Measles Virus Large structural Protein RNA Polymerase - Protein L; Transcriptase; Replicase N_A 1 mg
10-663-45516 Measles Virus Large structural Protein RNA Polymerase - Protein L; Transcriptase; Replicase N_A 0.5 mg
10-663-45516 Measles Virus Large structural Protein RNA Polymerase - Protein L; Transcriptase; Replicase N_A 0.1 mg
orb81732 HIV-2 gp32 protein HIV-2 gp32 recombinant- contains the full-length sequence of HIV-2 envelope immunodominant regions gp32. The protein is fused with -galactosidase (114 kDa) at N-terminus. For resear 100
EIAAB38762 Cape,Chromosome-associated protein E,FGF-inducible protein 16,Fin16,Mouse,Mus musculus,SMC protein 2,Smc2,SMC-2,Smc2l1,Structural maintenance of chromosomes protein 2,XCAP-E homolog
228-10674-3 Recombinant Hepatitis C Virus Non-structural Protein 4b (NS4b) Antigen 1000
MD-05-0217 Goat Anti-Hepatitis C Virus Non-structural Protein 5 a + b (NS5a+b) Antigen 1 mL
27-617 ZC3H7B is a protein that contains a tetratricopeptide repeat domain. The encoded protein also interacts with the rotavirus non-structural protein NSP3. 0.1 mg
DS-MB-01485 Mouse Anti-Hepatitis C Virus Non-structural Protein 4a (NS4a) Antigen 100
MD-05-0210 Mouse Anti-Hepatitis C Virus Non-structural Protein 4b (NS4b) Antigen (aa 1710-1730) 100
MD-14-0870 Mouse Anti-Hepatitis C Virus Non-structural Protein 4b (NS4b) Antigen (aa 1689-1735) 100
MD-14-0388P Recombinant Hepatitis C Virus Non-structural Protein 4 a + b (NS4a+b) Antigen (aa 1658-1863) 500
MD-14-0390P Recombinant Hepatitis C Virus Non-structural Protein 4 a + b ( NS4a+b ) Antigen (aa 1658-1863) 100
MD-14-0389P Recombinant Hepatitis C Virus Non-structural Protein 4 a + b ( NS4a+b ) Antigen (aa 1658-1863) 100
EIAAB39885 Chondroitin sulfate proteoglycan core protein,Cytolytic granule proteoglycan core protein,PG19 core protein,Pgsg,Prg,Prg1,Proteoglycan 10K core protein,Rat,Rattus norvegicus,Secretory granule proteogl


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur